GSK gets speedy USFDA nod for Jemperli ruchika21 Aug 2021 5:30 AM GMTUK: GlaxoSmithKline (GSK) plc has recently announced that the US Food and Drug Administration (USFDA) approved a new indication for JEMPERLI (dostarlim...
GSK gets CDSCO marketing authorization for Rotavirus Vaccine, Live Attenuated, Oral IP Medical Dialogues Team20 Aug 2021 10:37 AM GMTNew Delhi: The pharmaceutical major, GlaxoSmithKline Pharmaceuticals Limited, has recently received a grant of marketing authorization for Rotavirus Va...
GSK, Sanofi COVID vaccine Phase 2 trial shows strong immune responses across all adult age groups ruchika18 May 2021 4:30 AM GMTParis: The Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates of neutralizing antibody responses, in line with thos...
GSK cancer drug JEMPERLI gets speedy USFDA approval ruchika25 April 2021 4:00 AM GMTLondon: GlaxoSmithKline plc has recently announced that the US Food and Drug Administration (USFDA) has approved JEMPERLI (dostarlimab-gxly), a program...
GSK to sell Vemgal plant to Hetero Labs for Rs 180 crore ruchika2 April 2021 6:44 AM GMTNew Delhi: Drug firm GlaxoSmithKline Pharmaceuticals on Wednesday said its board has approved the sale of its manufacturing facility located at Vemgal ...
GSK gets EMA panel recommendation to approve Benlysta for adult patients with active lupus nephritis ruchika29 March 2021 4:00 AM GMTUK: GlaxoSmithKline plc (GSK) has recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (E...
GSK, Vir Biotechnology submit EUA request to USFDA for VIR-7831 for early Covid-19 treatment ruchika28 March 2021 5:00 AM GMTLondon and San Francisco: GlaxoSmithKline plc and Vir Biotechnology, Inc. have recently announced the submission of an application to the U.S. Food and...
GSK, Vir Biotechnology to halt enrollment in US COVID-19 antibody trial sub-study ruchika4 March 2021 10:20 AM GMTNew Delhi: Vir Biotechnology and Britain's GSK said on Wednesday they would pause enrollment into a study testing their experimental COVID-19 antibody ...
Sanofi, GSK begin Phase 2 study of protein-based COVID-19 vaccine ruchika23 Feb 2021 6:33 AM GMTParis and London: Sanofi and GSK have recently announced the initiation of a new Phase 2 study with 720 volunteers aged 18 and over to select the most ...
Bharat Biotech, GSK, PATH enter into product transfer agreement for malaria vaccine ruchika28 Jan 2021 11:22 AM GMTNew Delhi: GSK, PATH, and Bharat Biotech (BBIL) have recently announced the signing of a product transfer agreement for the malaria vaccine, RTS,S/AS0...
GSK Consumer Healthcare launches Otrivin Breathe Clean Daily Nasal Wash ruchika19 Dec 2020 5:30 AM GMTThe product comes in a contemporary aerosol spray format.
Sanofi, GSK delay Covid vaccine program to improve immune response MD Bureau13 Dec 2020 4:30 AM GMTNew Delhi: Sanofi and GSK have announced a delay in their adjuvanted recombinant protein-based Covid-19 vaccine programme to improve immune response in...
